Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1.
|
Cell Metab
|
2006
|
4.98
|
2
|
Dietary fructose reduces circulating insulin and leptin, attenuates postprandial suppression of ghrelin, and increases triglycerides in women.
|
J Clin Endocrinol Metab
|
2004
|
3.54
|
3
|
Frequency of abnormal carbohydrate metabolism and diabetes in a population-based screening of adolescents.
|
J Pediatr
|
2005
|
3.23
|
4
|
A controlled high-fat diet induces an obese syndrome in rats.
|
J Nutr
|
2003
|
2.80
|
5
|
Ghrelin suppresses glucose-stimulated insulin secretion and deteriorates glucose tolerance in healthy humans.
|
Diabetes
|
2010
|
2.01
|
6
|
Sequential intensification of metformin treatment in type 2 diabetes with liraglutide followed by randomized addition of basal insulin prompted by A1C targets.
|
Diabetes Care
|
2012
|
1.73
|
7
|
Cooperation between brain and islet in glucose homeostasis and diabetes.
|
Nature
|
2013
|
1.59
|
8
|
High-density lipoprotein maintains skeletal muscle function by modulating cellular respiration in mice.
|
Circulation
|
2013
|
1.51
|
9
|
Factors associated with insulin and narcotic independence after islet autotransplantation in patients with severe chronic pancreatitis.
|
J Am Coll Surg
|
2005
|
1.48
|
10
|
The pharmacokinetics of acyl, des-acyl, and total ghrelin in healthy human subjects.
|
Eur J Endocrinol
|
2013
|
1.36
|
11
|
Total pancreatectomy and autologous islet cell transplantation as a means to treat severe chronic pancreatitis.
|
J Gastrointest Surg
|
2003
|
1.35
|
12
|
Fibroblast growth factor 21 mediates specific glucagon actions.
|
Diabetes
|
2013
|
1.20
|
13
|
Physiologic concentrations of exogenously infused ghrelin reduces insulin secretion without affecting insulin sensitivity in healthy humans.
|
J Clin Endocrinol Metab
|
2013
|
1.08
|
14
|
Consumption of a high-fat diet induces central insulin resistance independent of adiposity.
|
Physiol Behav
|
2011
|
1.07
|
15
|
Ghrelin, obesity and diabetes.
|
Nat Clin Pract Endocrinol Metab
|
2007
|
1.06
|
16
|
The regulation of the lymphatic secretion of glucagon-like peptide-1 (GLP-1) by intestinal absorption of fat and carbohydrate.
|
Am J Physiol Gastrointest Liver Physiol
|
2007
|
1.04
|
17
|
Ghrelin enhances olfactory sensitivity and exploratory sniffing in rodents and humans.
|
J Neurosci
|
2011
|
1.04
|
18
|
Role of carbohydrate modification in weight management among obese children: a randomized clinical trial.
|
J Pediatr
|
2012
|
1.03
|
19
|
Using the lymph fistula rat model to study the potentiation of GIP secretion by the ingestion of fat and glucose.
|
Am J Physiol Gastrointest Liver Physiol
|
2008
|
1.00
|
20
|
Increased dietary fat attenuates the anorexic effects of intracerebroventricular injections of MTII.
|
Endocrinology
|
2003
|
0.95
|
21
|
Overweight and Hyperinsulinemia Provide Individual Contributions to Compromises in Brachial Artery Distensibility in Healthy Adolescents and Young Adults: Brachial Distensibility in Children.
|
J Am Soc Hypertens
|
2007
|
0.91
|
22
|
C75 inhibits food intake by increasing CNS glucose metabolism.
|
Nat Med
|
2003
|
0.89
|
23
|
Obesity induced by a high-fat diet downregulates apolipoprotein A-IV gene expression in rat hypothalamus.
|
Am J Physiol Endocrinol Metab
|
2004
|
0.88
|
24
|
Apolipoprotein A-IV interacts synergistically with melanocortins to reduce food intake.
|
Am J Physiol Regul Integr Comp Physiol
|
2005
|
0.87
|
25
|
Glucagon-like peptide 1: continued advances, new targets and expanding promise as a model therapeutic.
|
Curr Opin Endocrinol Diabetes Obes
|
2007
|
0.86
|
26
|
One-year sustained glycemic control and weight reduction in type 2 diabetes after addition of liraglutide to metformin followed by insulin detemir according to HbA1c target.
|
J Diabetes Complications
|
2013
|
0.86
|
27
|
Ghrelin stimulation of growth hormone isoforms: parallel secretion of total and 20-kDa growth hormone and relation to insulin sensitivity in healthy humans.
|
J Clin Endocrinol Metab
|
2012
|
0.85
|
28
|
The effect of chronic twice daily exenatide treatment on β-cell function in new onset type 2 diabetes.
|
Clin Endocrinol (Oxf)
|
2013
|
0.84
|
29
|
Contributions of fat and protein to the incretin effect of a mixed meal.
|
Am J Clin Nutr
|
2011
|
0.84
|
30
|
Investigation of the mechanisms contributing to the compensatory increase in insulin secretion during dexamethasone-induced insulin resistance in rhesus macaques.
|
J Endocrinol
|
2013
|
0.84
|
31
|
Impaired insulin secretion and enhanced insulin sensitivity in cholecystokinin-deficient mice.
|
Diabetes
|
2011
|
0.83
|
32
|
Enteroinsular signaling: perspectives on the role of the gastrointestinal hormones glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide in normal and abnormal glucose metabolism.
|
Curr Opin Clin Nutr Metab Care
|
2003
|
0.82
|
33
|
The intestinal lymph fistula model--a novel approach to study ghrelin secretion.
|
Am J Physiol Gastrointest Liver Physiol
|
2009
|
0.82
|
34
|
Chylomicron formation and secretion is required for lipid-stimulated release of incretins GLP-1 and GIP.
|
Lipids
|
2012
|
0.80
|
35
|
Ghrelin and hypothalamic development: too little and too much of a good thing.
|
J Clin Invest
|
2015
|
0.79
|
36
|
Prevalence of obesity and cardiovascular risk factors among manufacturing company employees in Kentucky.
|
AAOHN J
|
2007
|
0.78
|
37
|
The incretins and beta-cell health: contrasting glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 as a path to understand islet function in diabetes.
|
Gastroenterology
|
2009
|
0.78
|
38
|
The role of the transcription factor ETV5 in insulin exocytosis.
|
Diabetologia
|
2013
|
0.78
|
39
|
Building Momentum: Taking on the Real “Issues” of Diabetes Care!
|
Diabetes Care
|
2016
|
0.78
|
40
|
Obesity and insulin resistance: is it due to body fat, energy balance, or gut factors?
|
Curr Opin Clin Nutr Metab Care
|
2006
|
0.77
|
41
|
Give the receptor a brake: slowing gastric emptying by GLP-1.
|
Diabetes
|
2014
|
0.77
|
42
|
Eating disorders and gastrointestinal peptides.
|
Curr Opin Endocrinol Diabetes Obes
|
2011
|
0.76
|
43
|
How are we going to understand (dys)regulation of glucose metabolism?
|
Curr Opin Clin Nutr Metab Care
|
2004
|
0.75
|